Education
About Us
Working with TipRanks
Follow Us
Keros Therapeutics (KROS)
NASDAQ:KROS
Keros Therapeutics (KROS) Ownership Overview
22.43% Insiders
12.63% Mutual Funds
35.66% Other Institutional Investors
12.73% ETFs
16.56% Public Companies and Individual Investors
The ownership structure of Keros Therapeutics (KROS) stock is a mix of institutional, retail, and individual investors. Approximately 61.02% of the company’s stock is owned by Institutional Investors, 22.43% is owned by Insiders, and 16.56% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 11, 2025 | xxxxxxxxxxxxx | $9462056 | |
Aug 15, 2024 | xxxxxxxxxxxxx | $11002500 | |
Aug 15, 2024 | xxxxxxxxxxxxx | $11002500 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $365566 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $1374773 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,390,964 | Insider | 13.27% | 75,850,863 | |
| 1,971,145 | Institution | 4.85% | 27,734,010 | |
| 1,505,413 | Institution | 3.71% | 21,181,161 | |
| 1,454,245 | Institution | 3.58% | 20,461,227 | |
| 1,226,412 | Insider | 3.02% | 17,255,617 | |
| 1,226,412 | Insider | 3.02% | 17,255,617 | |
| 740,736 | Institution | 1.82% | 10,422,156 | |
| 575,492 | Insider | 1.42% | 8,097,172 | |
| 444,371 | Institution | 1.09% | 6,252,300 | |
| 433,323 | Institution | 1.07% | 6,096,855 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,505,413 | Institution | 3.71% | 21,181,161 | |
| 433,323 | Institution | 1.07% | 6,096,855 | |
| 388,000 | Institution | 0.96% | 5,459,160 | |
| 377,478 | Institution | 0.93% | 5,311,115 | |
| 350,534 | Institution | 0.86% | 4,932,013 | |
| 345,328 | Institution | 0.85% | 4,858,765 | |
| 324,443 | Institution | 0.80% | 4,564,913 | |
| 215,561 | Institution | 0.53% | 3,032,943 | |
| 170,109 | Institution | 0.42% | 2,393,434 | |
| 113,200 | Institution | 0.28% | 1,592,724 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,092,345 | Institution | 2.69% | 15,773,462 | |
| 845,477 | Institution | 2.08% | 11,895,861 | |
| 660,370 | Institution | 1.63% | 9,264,991 | |
| 578,177 | Institution | 1.42% | 8,348,876 | |
| 300,805 | Institution | 0.74% | 4,232,326 | |
| 294,408 | Institution | 0.72% | 4,142,321 | |
| 207,960 | Institution | 0.51% | 2,925,997 | |
| 166,016 | Institution | 0.41% | 2,397,271 | |
| 163,455 | Institution | 0.40% | 2,293,274 | |
| 145,589 | Institution | 0.36% | 2,048,437 |
FAQ
Who Owns Keros Therapeutics (KROS)?
According to the latest TipRanks data, approximately 35.66% of the company's stock is held by institutional investors, 22.43% is held by insiders, and 16.56% is held by retail investors.
What percentage of Keros Therapeutics (KROS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 35.66% of Keros Therapeutics (KROS) stock is held by institutional investors.
What percentage of Keros Therapeutics (KROS) stock is held by retail investors?
According to the latest TipRanks data, approximately 16.56% of Keros Therapeutics (KROS) stock is held by retail investors.
Who owns the most shares of Keros Therapeutics (KROS)?
ADAR1 Capital Management, LLC owns the most shares of Keros Therapeutics (KROS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.